Simbrinza Drops 10mg/2mg

SIMBRINZA® Eye Drops contain Brinzolamide 10mg/mL (1%) and Brimonidine Tartrate 2mg/mL (0.2%). Manufactured by Novartis, this prescription ophthalmic suspension is indicated for the treatment of open-angle glaucoma and ocular hypertension in adults when a single medication does not adequately reduce intraocular pressure (IOP). The dual-action formula combines a carbonic anhydrase inhibitor and an alpha-2 adrenergic agonist to effectively lower eye pressure, helping protect the optic nerve and reduce the risk of vision loss associated with glaucoma.

Uses

• Open-angle glaucoma
• Ocular hypertension (high pressure inside the eye)
• Reduction of elevated intraocular pressure (IOP)
• Patients requiring combination therapy when monotherapy is insufficient

Advantages / Benefits

• Contains Brinzolamide 10mg/mL + Brimonidine Tartrate 2mg/mL
• Dual-action formula for enhanced IOP reduction
• Helps protect the optic nerve from glaucoma-related damage
• May reduce the risk of progressive vision loss
• Convenient ophthalmic suspension for twice-daily use as prescribed

Possible Side Effects

Common side effects may include:

• Blurred vision immediately after instillation
• Eye irritation or redness
• Dry eyes
• Bitter or unusual taste in the mouth
• Eye discomfort
• Dry mouth
• Drowsiness or fatigue
• Allergic eye reactions

Seek immediate medical attention if you experience severe eye pain, significant vision changes, swelling of the face, or signs of a serious allergic reaction.

Pharmacist's Advice

• Use only as prescribed by your ophthalmologist.
• Shake the bottle well before each use.
• Wash your hands before applying the drops and avoid touching the dropper tip to any surface.
• Remove contact lenses before use and wait at least 15 minutes before reinserting them.
• If using more than one eye medication, allow 5–10 minutes between different eye drops.
• Do not discontinue treatment without consulting your eye specialist, even if symptoms improve.
• Discard the bottle 4 weeks after first opening to reduce the risk of eye infection.